申请人:HOFFMANN LA ROCHE
公开号:WO2000035920A2
公开(公告)日:2000-06-22
Novel 4,5-azolo-oxindoles having formula (I), wherein R1, R2, Y, Z and a have the meaning indicated in the specification, inhibit cyclin-dependent kinases (CDKs), in particular CDK2 and are useful in the treatment or control of cell proliferative disorders, in particular cancer.